Normal
20th-21st October 2022

5th Annual MarketsandMarkets Real-World Evidence and Life Sciences Analytics Conference

MarketsandMarkets is proud to announce the 5th Annual Real-World Evidence and Life Sciences Conference to be held on October 20-21, 2022 in Boston, USA.

Real-world data and real-world evidence are poised to keep making strides in 2022.
The emergence of this pandemic has posed severe financial constraints on pharma-biopharma companies in several countries. In this regard, RWE solutions have proven to be extremely useful, as they allow industrial and academic researchers to monitor patients using digitally connected platforms while assisting to organize and evaluate clinical data for regulatory submissions.
 

Shifts in healthcare coverage and provision during the pandemic have changed the discovery and reporting of certain outcomes in data and the treated population. This means that disease trends may lead to incorrect interpretations when RWD and RWE are not framed in the context of the pandemic and long-term COVID-19 disease, therapy, and lifestyle changes. Telemedicine and virtual care may also provoke a greater adoption of technologies such as wearables and digital therapeutics, thus accelerating digitalization in the healthcare space and boosting the importance of RWE and AI.

Additionally with the new guidance by the FDA around data quality and data standards, the stakeholders are seeking to learn its long term impact and safety surveillance.
This conference will focus on above said significant points and hold discussions on the best practices adopted by various stakeholders with a key takeaway being better decision making.

WHAT TO EXPECT

Key Highlights

  • Regulatory view around data quality & data standards.
  • Leveraging RWE for improving market access.
  • The adoption & role of AI & ML in clinical trials.
  • Real-world evidence & Digital Health - The expanded role of RWE for digital health.
  • Panel Discussion on lessons learned from the recent results of the FDA’s
    pilot program RCT DUPLICATE.
  • Real-World Data & Advanced Analytics.
  • RWE to inform decision making process in rare diseases where there is lack of evidence.

Why Attend?

  • Learn about the recent trends and advancements in Real-World Evidence Generation
  • Engage in meaningful discussion with the most prominent industry experts and decision makers from pharmaceutical and biopharmaceutical companies who will address most critical challenges in real-world data and real-world evidence space.
  • Opportunity to network and exchange scientific knowledge with expert speakers from leading pharmaceutical companies, global regulators and solution providers

Who Should Attend?

From pharmaceutical and Biopharmaceutical companies

Chief executives, VP’s, Directors, Global heads, Heads, Leaders, Senior Managers, Researcher, Analysts, Investigators, Scientists within the following departments-

Real-World Evidence, Real-World Data, Health Economics & Outcomes Research- HEOR, Market Access/Value Access, Clinical Outcomes, Clinical Development & research, Clinical trial and others

CONFERENCE AGENDA
Real-World Evidence and Digital Health-The Expanded Role of RWE for Digital Health
Real-World Data Advanced Analytics
CONFERENCE SPEAKERS
Advisors
Charles Makin
Charles Makin
Global Head, Real World Evidence Strategy , Biogen
Nneka Onwudiwe
Nneka Onwudiwe
Former PRO/PE Regulatory Review Officer, FOOD AND DRUG ADMINISTRATION
Joel Iff
Joel Iff
Senior Director Global Market Access, Sarepta Therapeutics, USA
Melva Covington
Melva Covington
Senior Vice President, Research and Patient Outcomes, Curio Digital Therapeutics
Speakers
Charles Makin
Charles Makin
Global Head, Real World Evidence Strategy , Biogen
Nneka Onwudiwe
Nneka Onwudiwe
Former PRO/PE Regulatory Review Officer, FOOD AND DRUG ADMINISTRATION
Joel Iff
Joel Iff
Senior Director Global Market Access, Sarepta Therapeutics, USA
Melva Covington
Melva Covington
Senior Vice President, Research and Patient Outcomes, Curio Digital Therapeutics
Eric Sarpong
Eric Sarpong
Director, Real-World Data Analytics and Innovation, Centre for Observation and Real-World Evidence (CORE), Merck
Huan Huang
Huan Huang
Director, HEOR, G1 Therapeutics, Inc.
Jennifer Webster
Jennifer Webster
Senior Director, Precision Medicine RWE Lead, Pfizer
SPONSORS
Exhibition Partner
example-image

Adelphi Real World

PAST EVENT GALLERY